Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sanofi SA (NYSE:SNY)

50.34
Delayed Data
As of Sep 22
 +0.39 / +0.78%
Today’s Change
36.81
Today|||52-Week Range
50.65
+24.48%
Year-to-Date
Alnylam/Sanofi's RNAi Drug Meets Endpoint in Study, Stock Up
Sep 21 / Zacks.com - Paid Partner Content
Lilly/Incyte's Baricitinib Meets Endpoint in Eczema Study
Sep 15 / Zacks.com - Paid Partner Content
Is Sanofi (SNY) a Great Stock for Value Investors?
Sep 21 / Zacks.com - Paid Partner Content
AstraZeneca's Asthma Candidate Shows Promising Results
Sep 12 / Zacks.com - Paid Partner Content
Silverback Asset Management Llc Buys Becton, Dickinson and Co, Sanofi Contingent Valu...
Sep 18 / GuruFocus News - Paid Partner Content
Regeneron/Sanofi's Dupixent Asthma Study Meets Endpoints
Sep 11 / Zacks.com - Paid Partner Content